A Long-term Study of Mometasone Furoate in Patients With Perennial Allergic Rhinitis (Study P04459)
Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
This study examined the safety and effectiveness of long-term administration of mometasone
nasal spray in patients with perennial allergic rhinitis. Patients received mometasone for 12
weeks plus an additional 12 weeks if patient agreed to continue. Dose of mometasone could be
decreased or increased during the study based on patient's response.